| PERIOD ENDING | 23-Oct-09 | 24-Jul-09 | 24-Apr-09 | 23-Jan-09 | | Total Revenue | 40,718 | 38,501 | 38,577 | 35,260 | | Cost of Revenue | 5,118 | 5,340 | 5,112 | 4,934 | | | Gross Profit | 35,600 | 33,161 | 33,466 | 30,326 | | | Operating Expenses | | Research Development | 5,145 | 5,030 | 5,189 | 5,130 | | Selling General and Administrative | 21,372 | 21,619 | 21,568 | 20,213 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,083 | 6,512 | 6,708 | 4,983 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,029 | 2,059 | 664 | 5,782 | | Earnings Before Interest And Taxes | 10,112 | 8,572 | 7,372 | 10,764 | | Interest Expense | 431 | 503 | 608 | 697 | | Income Before Tax | 9,681 | 8,069 | 6,765 | 10,068 | | Income Tax Expense | (40,463) | 203 | 242 | 273 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 52,341 | 7,865 | 6,523 | 9,795 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,144 | 7,865 | 6,523 | 9,795 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $50,144 | $7,865 | $6,523 | $9,795 |
|
0.02% Nasdaq 
0.33%
Income Statement
